RT Journal Article
SR Electronic
T1 841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A939
OP A939
DO 10.1136/jitc-2023-SITC2023.0841
VO 11
IS Suppl 1
A1 Wang, Baohui
A1 Wang, Hailin
A1 Li, Tingting
A1 Sun, Jianming
A1 Huang, Xiao
A1 Lin, Huan
A1 Dan, Yujia
A1 Qin, Yurong
A1 Zhang, Peng
A1 Guan, Jing
A1 Wu, Guojin
A1 Hou, Xiaofan
A1 Lai, Shoupeng
A1 Kang, Xiaoqiang
A1 Ling, Hong
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A939.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.